Lonza is a Swiss company established in 1897, operating primarily in the manufacturing sector with a significant focus on pharmaceuticals and biotechnology. The company employs over 10,001 individuals and reported a revenue of approximately $8.94 billion. Lonza's expertise encompasses various areas, including pharmaceuticals, corporate services, and research, indicating a strong presence in both the manufacturing and research domains. The company engages in the development and production of active pharmaceutical ingredients, as well as providing services and solutions to the biotech and pharmaceutical industries. Lonza's published content includes a research article that reflects its commitment to advancing knowledge in its field, highlighting its role in scientific research and innovation. The limited document corpus suggests a focus on specialized topics within the pharmaceutical and biotech sectors, aligning with its overall business strategy. As a key player in the manufacturing industry, Lonza continues to contribute to advancements in pharmaceuticals and biotechnology through its research and development initiatives.